Literature DB >> 33571789

Peabody Developmental Motor Scales - Second Edition (PDMS-2): Reliability, content and construct validity evidence for Brazilian children.

Larissa Wagner Zanella1, Nadia Cristina Valentini2, Fernando Copetti3, Glauber Carvalho Nobre4.   

Abstract

BACKGROUND: The Peabody Developmental Motor Scales - Second Edition (PDMS-2) has been used by health and educational professionals to assess the gross and fine motor skills of children with typical development, motor and/or cognitive delays, and disabilities. AIM: Investigate the validity and reliability of PDMS-2 for use in Brazil.
METHODS: For content validity, 13 professionals participated in the study. For construct validity, a sample of 637 children from birth until 71 months (0-23 months: n = 399; 24-71 months: n = 238) was assessed with the PDMS-2.
RESULTS: The PDMS-2 administered to the Brazilian population has psychometric characteristics equivalent to the original version.
CONCLUSION: PDMS-2 is a valid and reliable tool for evaluating Brazilian children's motor development and providing appropriate support for clinical and educational intervention plans and follow-ups.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Children; Construct validity; Content validity; Infants; Motor development; Validation of instruments

Mesh:

Year:  2021        PMID: 33571789     DOI: 10.1016/j.ridd.2021.103871

Source DB:  PubMed          Journal:  Res Dev Disabil        ISSN: 0891-4222


  2 in total

1.  Peabody Developmental Motor Scales-2: The Use of Rasch Analysis to Examine the Model Unidimensionality, Motor Function, and Item Difficulty.

Authors:  Nadia Cristina Valentini; Larissa Wagner Zanella
Journal:  Front Pediatr       Date:  2022-04-20       Impact factor: 3.569

2.  Is Motor Milestone Assessment in Infancy Valid and Scaled Equally Across Sex, Birth Weight, and Gestational Age? Findings From the Millennium Cohort Study.

Authors:  Denise de Almeida Maia; Farid Bardid; Tobias Koch; Paola Okuda; George Ploubidis; Anders Nordahl-Hansen; Michael Eid; Hugo Cogo-Moreira
Journal:  Front Psychol       Date:  2022-01-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.